PELL Bio-Med Technology Co Ltd(TW:6949)
NT$44.75+3.20 (+7.70%)
TW:6949
PELL Bio-Med Technology Co Ltd financials statements
NT$44.75
At close:+3.20 (+7.70%)
PELL Bio-Med Technology Co Ltd (6949) Income Statement
PELL Bio-Med Technology Co Ltd Income Statement
Last quarter (Q2 2026), PELL Bio-Med Technology Co Ltd's total revenue was NT$8.95M, an increase of 52.47% from the same quarter last year. In Q2, PELL Bio-Med Technology Co Ltd's net income was NT$-88.90M. See PELL Bio-Med Technology Co Ltd’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| NT$ 31.42M | NT$ 19.63M | NT$ 18.03M | NT$ 17.16M | NT$ 13.98M | |
| NT$ -4.39M | NT$ -12.33M | NT$ -26.14M | NT$ -42.30M | NT$ -34.53M | |
| NT$ 462.96M | NT$ 401.17M | NT$ 385.11M | NT$ 193.81M | NT$ 161.43M | |
| Depreciation and Amortization | NT$ 47.12M | NT$ 46.88M | NT$ 45.61M | NT$ 31.04M | NT$ 30.16M |
| NT$ -420.23M | NT$ -346.09M | NT$ -353.18M | NT$ -198.87M | NT$ -157.29M | |
| NT$ -467.35M | NT$ -413.50M | NT$ -411.25M | NT$ -236.11M | NT$ -195.96M | |
| NT$ 14.68M | NT$ 18.38M | NT$ 10.01M | NT$ 4.84M | NT$ 6.99M | |
| NT$ -452.67M | NT$ -395.12M | NT$ -401.24M | NT$ -231.27M | NT$ -188.97M | |
| NT$ -423.94M | NT$ -389.42M | NT$ -398.76M | NT$ -230.13M | NT$ -188.96M | |
| Per Share Metrics | |||||
| Basic EPS | NT$ -0.36 | NT$ -0.34 | NT$ -0.43 | NT$ -0.29 | NT$ -0.28 |
| Diluted EPS | NT$ -0.36 | NT$ -0.34 | NT$ -0.43 | NT$ -0.29 | NT$ -0.28 |
| Weighted Average Shares Outstanding | 1.17B | 1.14B | 925.19M | 784.48M | 665.54M |
| Weighted Average Shares Outstanding (Diluted) | 1.17B | 1.14B | 925.19M | 784.48M | 665.54M |
Currency in TWD

